Who owns INHIBIKASE THERAPEUTICS INC?
- Ticker: IKT
- CUSIP Number: 45719w205
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibikase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibikase Therapeutics stock
Who bought or sold INHIBIKASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 82k | $104k | -6% | Dec 2023 |
|
| William Blair $ Company | 60k | $77k | 2% | Dec 2023 |
|
| Redmond Asset Management | 20k | $25k | -6% | Dec 2023 |
|
| Royal Bank of Canada | 2.0k | $3.0k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 201.00 | $255.169500 | -13% | Dec 2023 |
|
| Bank of America Corporation | 62.00 | $79.000400 | 100% | Dec 2023 |
|
Who sold out of Inhibikase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 149.00 | $207.005700 |